In the healthcare industry, public trust is not built overnight. It grows through consistent quality assurance, adherence to standards, and contributions that are tangibly felt by society. As demands for transparency continue to rise, healthcare companies are expected not only to deliver good products, but also to establish accurate and responsible communication. For more than five decades, Dexa Group has embraced the philosophy Expertise for the Promotion of Health as the fo

Dexa Medica has once again affirmed its role as a pioneer in Indonesia’s pharmaceutical industry through an award presented by the National Agency of Drug and Food Control (BPOM) of the Republic of Indonesia. The BPOM Achievement Award 2026 in the category of Pioneer with the Highest Number of Phytopharmaceutical Products in Indonesia was presented by the Head of BPOM RI, Prof. Dr. Taruna Ikrar, to the President Director of PT Dexa Medica, Mr. V. Hery Sutanto. The award cerem

Dexa Group has once again achieved a strategic milestone by receiving the Indonesia CEO Excellence Award 2025, organized by WartaEkonomi.co.id Research and Consulting. This award recognizes visionary leadership that consistently drives business sustainability while strengthening the pharmaceutical sector’s contribution to national health resilience. The award was presented by Muhamad Ihsan, CEO & Chief Editor of WartaEkonomi.co.id, to Andy Samual, Director of Human Resources

On the occasion of the 61st National Health Day (HKN), Dexa Medica achieved a significant milestone by receiving the Karya Anak Bangsa Award from the Ministry of Health of the Republic of Indonesia, recognizing it as the pharmaceutical industry with the highest number of clinical trials for natural-based drugs in the country. The award was presented during the Health Innovation Festival (HAI-Fest) 2025 held at Kartika Expo Balai Kartini, Jakarta, on Monday, December 8, 2025.

As global interest in herbal medicines continues to grow, only a limited number of products are developed with rigorous scientific methods and supported by strong clinical evidence. DLBS addresses this gap through the development of Integrative Modern Natural Medicines—therapeutics based on defined bioactive fractions with clear mechanisms of action and clinically validated efficacy (phytopharmaceuticals) in accordance with Good Clinical Practice. This commitment was showcase

Minister of Health Budi Gunadi Sadikin has set a target for 60–70 million Indonesians to receive free health screenings by 2025. In support of this initiative, PT Dexa Medica continues to contribute through its Cek Segitiga Gratis program, which recently took place at the Car Free Day area on Boulevard Makassar, Sunday, October 26, 2025. The event received an enthusiastic response from Makassar residents, with more than 400 participants taking part in free checks for blood pr

A delegation from the World Health Organization (WHO) and Indonesia’s National Agency for Drug and Food Control (BPOM RI) visited Dexa Laboratories of Biomolecular Sciences (DLBS) to observe firsthand how Indonesia’s biodiversity is being utilized in pharmaceutical research for the development of Modern Indonesian Natural Medicine (OMAI). Prof. Raymond Tjandrawinata, Director of Business Development and Scientific Affairs at PT Dexa Medica, shared the journey of DLBS in devel

Dexa Medica once again demonstrates its strong commitment as a national pharmaceutical company that plays a vital role in strengthening Indonesia’s pharmaceutical independence, particularly through the development of natural-based medicines. This commitment was reflected in its active contribution to the prestigious 16th Annual Meeting of the WHO–International Regulatory Cooperation for Herbal Medicines (IRCH), held at JS Luwansa Hotel and Convention Center, Jakarta, on Tuesd

Non-Communicable Diseases (NCDs) such as hypertension, diabetes, and high cholesterol are increasingly becoming a threat to public health in Indonesia. These three silent killers often show no symptoms, yet have serious impacts on quality of life and healthcare costs. Responding to this challenge, PT Dexa Medica, through its Cek Segitiga initiative, once again provided free health checks for the public, this time at Bintaro Xchange Mall, South Tangerang, on Saturday, Septembe

Dexa Group achieved a remarkable milestone by receiving two prestigious awards in a single day, underscoring its commitment to ensuring halal assurance across all products and facilities. The recognitions came from Indonesia’s Ministry of Industry (Kemenperin) and the Halal Inspection Body of the Institute for Food, Drug, and Cosmetic Studies (LPH LPPOM), both official institutions for halal certification. The first recognition was the Indonesia Halal Industry Awards (IHYA) 2